October 26, 2018
ViiV Healthcare’s Juluca (dolutegravir + rilpivirine), which has been approved overseas as the world’s first two-drug complete HIV regimen taken in a once-daily single pill, will come up for review by a key health ministry panel on November 8. Juluca,...read more